Skip to Main Content

Paper Details

Efficacy of Tesevatinib in -Amplified Patient-Derived Xenograft Glioblastoma Models May Be Limited by Tissue Binding and Compensatory Signaling.
Molecular Cancer Therapeutics
7
2021

Datasets

Release 1.2